Standard Biotools Inc
Medical Devices
Healthcare
LAB
378 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
1.38
52 week high
2.92
high
1.44
52 week low
0.00
low
1.37
growth
-31.34 %
previous Close
1.40
P/E ratio
market cap
430 M
div yield
0
usd
Mar 2025
qoq
revenue
40.80 M
-12.68 %
net incoming
-26.03 M
23.59 %
eps
0.00 %
3.24 %
eps surprise
-19.50 %
net profit margin
-63.81 %
9.00 %
operating incoming
-32.97 M
-0.47 %
net change in cash
-15.35 M
64.41 %
cash on hand
151 M
-9.51 %
cost of revenue
21.05 M
-15.15 %
top top